Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Tommaso Za

Showing results (11-20 of 34) with videos related to

Pageof 4
Sort By:
European Journal of Nuclear Medicine and Molecular Imaging|July 29, 2018
Prognostic significance of normalized FDG-PET parameters in patients with multiple myeloma undergoing induction chemotherapy and autologous hematopoietic stem cell transplantation: a retrospective single-center evaluationDaria Ripani, Carmelo Caldarella, Tommaso Za, et al.
Haematologica|April 2, 2009
Influence of the JAK2 V617F mutation and inherited thrombophilia on the thrombotic risk among patients with essential thrombocythemiaValerio De Stefano, Tommaso Za, Elena Rossi, et al.
Hospital Pharmacy|February 23, 2026
Daratumumab in the Treatment of Multiple Myeloma: Real World Evidence (2018-2024) at the a. Gemelli Polyclinic (Rome) and Comparison With Registration StudiesMichele Favia, Michela Sperandeo, Lidia Di Cerbo, et al.
Haematologica|October 23, 2025
The impact of daratumumab-containing induction on stem cell mobilization, collection and engraftment in newly diagnosed multiple myeloma: results of the prospective DILEMMA studyCaterina Giovanna Valentini, Claudio Pellegrino, Patrizia Chiusolo, et al.
European Journal of Haematology|May 3, 2018
Cyclophosphamide's addition in relapsed/refractory multiple myeloma patients with biochemical progression during lenalidomide-dexamethasone treatmentLaura Cesini, Agostina Siniscalchi, Sara Grammatico, et al.
Mediterranean Journal of Hematology and Infectious Diseases|May 14, 2013
Chlorambucil plus Rituximab as Front-Line Therapy in Elderly/Unfit Patients Affected by B-Cell Chronic Lymphocytic Leukemia: Results of a Single-Centre ExperienceLuca Laurenti, Barbara Vannata, Idanna Innocenti, et al.
Leukemia Research|January 22, 2008
Early diagnosis followed by front-line autologous peripheral blood stem cell transplantation for patients affected by POEMS syndromeLuca Laurenti, Silvia De Matteis, Mario Sabatelli, et al.
Cytometry. Part B, Clinical Cytometry|December 9, 2017
Role of flow-cytometric immunophenotyping in prediction of BCR/ABL1 gene rearrangement in adult B-cell acute lymphoblastic leukemiaFrancesco Corrente, Silvia Bellesi, Elisabetta Metafuni, et al.
Journal of Experimental & Clinical Cancer Research : CR|March 3, 2012
IgD multiple myeloma a descriptive report of 17 cases: survival and response to therapyFrancesco Pisani, Maria Teresa Petrucci, Diana Giannarelli, et al.
Strahlentherapie Und Onkologie : Organ Der Deutschen Rontgengesellschaft ... [Et Al]|February 22, 2011
Impact of radiotherapy on pain relief and recalcification in plasma cell neoplasms: long-term experienceMario Balducci, Silvia Chiesa, Stefania Manfrida, et al.
Pageof 4

Showing results (11-20 of 34) with videos related to

Sort By:
Pageof 4
European Journal of Nuclear Medicine and Molecular Imaging|July 29, 2018
Prognostic significance of normalized FDG-PET parameters in patients with multiple myeloma undergoing induction chemotherapy and autologous hematopoietic stem cell transplantation: a retrospective single-center evaluationDaria Ripani, Carmelo Caldarella, Tommaso Za, et al.
Haematologica|April 2, 2009
Influence of the JAK2 V617F mutation and inherited thrombophilia on the thrombotic risk among patients with essential thrombocythemiaValerio De Stefano, Tommaso Za, Elena Rossi, et al.
Hospital Pharmacy|February 23, 2026
Daratumumab in the Treatment of Multiple Myeloma: Real World Evidence (2018-2024) at the a. Gemelli Polyclinic (Rome) and Comparison With Registration StudiesMichele Favia, Michela Sperandeo, Lidia Di Cerbo, et al.
Haematologica|October 23, 2025
The impact of daratumumab-containing induction on stem cell mobilization, collection and engraftment in newly diagnosed multiple myeloma: results of the prospective DILEMMA studyCaterina Giovanna Valentini, Claudio Pellegrino, Patrizia Chiusolo, et al.
European Journal of Haematology|May 3, 2018
Cyclophosphamide's addition in relapsed/refractory multiple myeloma patients with biochemical progression during lenalidomide-dexamethasone treatmentLaura Cesini, Agostina Siniscalchi, Sara Grammatico, et al.
Mediterranean Journal of Hematology and Infectious Diseases|May 14, 2013
Chlorambucil plus Rituximab as Front-Line Therapy in Elderly/Unfit Patients Affected by B-Cell Chronic Lymphocytic Leukemia: Results of a Single-Centre ExperienceLuca Laurenti, Barbara Vannata, Idanna Innocenti, et al.
Leukemia Research|January 22, 2008
Early diagnosis followed by front-line autologous peripheral blood stem cell transplantation for patients affected by POEMS syndromeLuca Laurenti, Silvia De Matteis, Mario Sabatelli, et al.
Cytometry. Part B, Clinical Cytometry|December 9, 2017
Role of flow-cytometric immunophenotyping in prediction of BCR/ABL1 gene rearrangement in adult B-cell acute lymphoblastic leukemiaFrancesco Corrente, Silvia Bellesi, Elisabetta Metafuni, et al.
Journal of Experimental & Clinical Cancer Research : CR|March 3, 2012
IgD multiple myeloma a descriptive report of 17 cases: survival and response to therapyFrancesco Pisani, Maria Teresa Petrucci, Diana Giannarelli, et al.
Strahlentherapie Und Onkologie : Organ Der Deutschen Rontgengesellschaft ... [Et Al]|February 22, 2011
Impact of radiotherapy on pain relief and recalcification in plasma cell neoplasms: long-term experienceMario Balducci, Silvia Chiesa, Stefania Manfrida, et al.
Pageof 4